Centrum Medyczne ENEL-MED (FRA:E19) Moat Score: 0/10 (As of Jul. 11, 2026)


FRA:E19 Centrum Medyczne ENEL-MED SA FRA:E19
78 GF Score
Price €4.12
GF Value €5.50
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED Moat Score?

Centrum Medyczne ENEL-MED has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Centrum Medyczne ENEL-MED has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Centrum Medyczne ENEL-MED might have No Moat - No discernible moat.

Centrum Medyczne ENEL-MED  (FRA:E19) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Centrum Medyczne ENEL-MED Moat Score Related Terms

FRA:E19
78GF Score
Centrum Medyczne ENEL-MED SA FRA:E19
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Centrum Medyczne ENEL-MED (FRA:E19) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of €4.12 is trading 25.1% below its estimated GF Value™ of €5.50.

Key valuation signals for FRA:E19:

  • Moat Score: 0
  • GF Value™: €5.50 vs. price of €4.12 (25.1% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the FRA:E19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centrum Medyczne ENEL-MED Business Description

Other Exchanges ENE:Poland
Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
78GF Score

Get the complete analysis for FRA:E19

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.12
Price
€5.50
GF Value